John Huang

John Huang is currently the Vice President of Biology at Iambic Therapeutics. Previously, John held positions such as Executive Director of Translational Research at TP Therapeutics, Inc., Director of Cell Biology at Halozyme Therapeutics, Inc., and Sr. Principal Scientist in Oncology Drug Development at Pfizer. With a strong background in preclinical pharmacology, in vivo and in vitro research, and drug discovery, John has extensive experience in leading teams and conducting studies to support clinical trials and regulatory filings. John also has a Ph.D in Biochemistry from the University of California, Riverside.